Plain-English translation of NCT04847063 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 1 โ Testing in a small group (usually 20โ80 people) to find a safe dose and watch for side effects.
This trial is testing a treatment called hyperthermic intraperitoneal chemotherapy (HIPEC) โ a heated chemotherapy delivered directly into the abdomen during surgery โ for people with certain cancers that have spread across the abdominal lining. Before your surgery, doctors will test your tumor cells in the lab with different chemotherapy drugs to see which one works best for you. This personalized approach could help your doctors choose the most effective medication for your specific cancer.
Currently, doctors choose chemotherapy drugs based mainly on the type of cancer you have and their own experience, rather than on what might work best for your individual tumor. This trial aims to prove that testing your tumor cells beforehand can predict which medication will be most effective, potentially improving your treatment outcomes.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you enroll, you will have surgery to remove as much cancer as possible from your abdomen. Before and during surgery, doctors will collect small samples of your tumor. They will test these samples in the lab using different heated chemotherapy drugs to see which one kills your cancer cells most effectively. Based on the results, you will receive one of several chemotherapy medications heated and delivered directly into your abdomen during the surgery. You will also need to participate in a related tissue collection study to help researchers understand how the treatment works.
AI-generated summary from trial data ยท Jul 17, 2026 ยท Not medical advice
United States